Company profile
UK company 09736075, incorporated on 17 August 2015.
Advanced microfluidic sensing - SouthWestSensor Ltd.
Southwestsensor Limited is a UK company with status active founded in 2015 based in South East England.
Company number 09736075
Financial period: 1 Sep 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
SouthWestSensor develops portable and wearable chemical sensors, with applications in the healthcare sector for continuous monitoring of chemicals in the body, as well as in the environmental sector to monitor the variation and distribution of chemicals in oceans, lakes, and rivers.
SouthWestSensor develops portable and wearable chemical sensors, with applications in the healthcare sector for continuous monitoring of chemicals in the body, as well as in the environmental sector to monitor the variation and distribution of chemicals i
SouthWestSensor Limited is a spin-out company from University of Southampton. The current market for wearable sensors is over £100M, growing at a CAGR of 47% in the next 5 years. Moreover the emergence of the mobile healthcare is likely to accelerate this market's growth by many folds. SouthWestSensor Limited (SWS) is positioned to capture this wave with its proprietary technology: Continuous chemical monitoring. The first product, named Fluicorder, is a palm-sized novel microfluidic based sensor device. The device is fully integrated and automatic, can sample biofluids up to a few thousand times per day (each sample only takes <2 nano-litres), and can analyse each sample in real-time to measure accurately the concentrations of biomolecules of interest (e.g. glucose, lactate, K+, or drug molecules, etc.), and communicate the data in real-time and wirelessly to clinicians or patients. The patent was filed in 2014 and is now in PCT stage. The prototype device has been designed and tested in the laboratory and is ready for tests in clinical settings. Early market investigation suggests the first target market segments are 1) Clinical or scientific researches and 2) drug development. There are no compitive technologies. SWS will design, manufacture and market the sensor devices, and obtaining revenues from sales, services and licensing.
Started to show impact of the advanced sensor technology by providing disruptive solutions.
1 Jun 2020 to 30 Nov 2020
no public description
1 Feb 2020 to 30 Sep 2020
Sepsis and trauma are among the most difficult, resource-intensive medical emergencies. Annual global sepsis cases are ~ 30m, with 6+m fatalities. UK has 250,000 sepsis cases annually with 46,000 deaths, costing £15.6 billion (York Health Economics Consortium). Annual US sepsis costs are $24bn, ~$14,000 per patient (Agency for Healthcare Research and Qual...
1 Aug 2017 to 31 Mar 2018
The wearable chemical sensor-cortisol project is an industrial research project that will allow SouthWestSensor (SWS) Ltd to offer a novel chemical sensor device for the measurement of cortisol, to be used in hospitals, community care and sport science. SWS Ltd has already established sensor devices for the measurement of chemical concentrations for a var...
